Detalhe da pesquisa
1.
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.
Future Oncol;
15(10): 1115-1123, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30887825
2.
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
BMC Cancer;
17(1): 493, 2017 Jul 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28724419
3.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol;
12(4): 493-502, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26776493
4.
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
BJU Int;
115(5): 764-71, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24988879
5.
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.
Future Oncol;
11(21): 2881-91, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26436290
6.
A new modified schedule of sunitinib for metastatic renal cell carcinoma: a retrospective analysis.
Acta Biomed;
83(2): 88-94, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23393915
7.
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
J Clin Pathol;
75(1): 39-44, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33144356
8.
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.
J Pers Med;
12(5)2022 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35629151
9.
Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions.
Expert Rev Anticancer Ther;
20(6): 491-501, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32479120
10.
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer.
Eur J Cancer;
140: 140-146, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33091718
11.
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study.
Eur Urol Oncol;
2(6): 699-707, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31542243
12.
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study.
Drugs R D;
18(2): 163, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29808389
13.
Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study.
Drugs R D;
17(4): 585-596, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28895069
14.
Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme.
Clin Genitourin Cancer;
14(1): 48-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26382222
15.
Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.
Eur Urol;
68(1): 147-53, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25457020
16.
When a thymic carcinoma "becomes" a GIST.
Lung Cancer;
80(1): 106-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23375402
17.
Systemic adjuvant therapies in renal cell carcinoma.
Oncol Rev;
6(2): e18, 2012 Oct 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25992216
18.
Changes in lymphocyte count induced by repeated cycles with low-dose interleukin-2 and interferon-α in 146 patients with renal cell carcinoma.
Tumori;
98(1): 45-52, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22495701
19.
Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study.
J Immunother;
33(7): 735-41, 2010 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20664353
20.
Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma.
J Clin Oncol;
29(33): e803-5, 2011 Nov 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21969494